Early-Phase Studies of Biomarkers: What Target Sensitivity and Specificity Values Might Confer Clinical Utility?

Pepe, Margaret S; Janes, Holly; Li, Christopher I; Bossuyt, Patrick M; Feng, Ziding; Hilden, Jørgen

Pepe, Margaret S; Janes, Holly; Li, Christopher I; Bossuyt, Patrick M; Feng, Ziding; Hilden, Jørgen.

Afiliação

Pepe MS; Biostatistics and Biomathematics Program, Public Health Sciences Division, mspepe@u.washington.edu.
Janes H; Vaccine and Infectious Disease Division, Public Health Sciences Division, and.
Li CI; Translational Research Program, Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, WA;
Bossuyt PM; Clinical Epidemiology, University of Amsterdam, Amsterdam, Netherlands;
Feng Z; Biostatistics, University of Texas MD Anderson Cancer Center, Houston, TX;
Hilden J; Department of Biostatistics, Institute of Medical Genetics, University of Copenhagen, Copenhagen, Denmark.

Clin Chem ; 62(5): 737-42, 2016 05.

Article em En | MEDLINE | ID: mdl-27001493

Assuntos

Biomarcadores Tumorais/análise; Neoplasias da Mama/diagnóstico; Neoplasias do Colo/diagnóstico; Neoplasias Ovarianas/diagnóstico; Idoso; Feminino; Humanos; Pessoa de Meia-Idade; Sensibilidade e Especificidade

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Neoplasias da Mama / Biomarcadores Tumorais / Neoplasias do Colo Tipo de estudo: Diagnostic_studies / Guideline / Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Middle aged Idioma: En Revista: Clin Chem Assunto da revista: QUIMICA CLINICA Ano de publicação: 2016 Tipo de documento: Article País de publicação: Reino Unido

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google